6 ASX stocks receiving analyst downgrades this week

Brokers reduced their ratings on NextDC, Ampol, Regis Resources, and other stocks this week. 

S&P/ASX 200 Index (ASX: XJO) stocks are 0.3% lower at 8,765 points on Friday.

Brokers have reduced their ratings on several ASX shares this week.

Let's review. 

Shot of a young businesswoman looking stressed out while working in an office.

Image source: Getty Images

NextDC Ltd (ASX: NXT)

The NextDC share price is $5.48, down 4.8% today.

Over the past month, this ASX tech share has more than halved in value.

Morgan Stanley downgraded NextDC shares to a hold rating today.

The broker slashed its 12-month price target from $19 to $6.70.

This still suggests a potential 22% upside ahead.

Ampol Ltd (ASX: ALD)

The Ampol share price is $38.99, down 2.2% today.

Over the past month, this ASX energy stock has lost 12% of its valuation.

RBC Capital downgraded Ampol shares to a hold rating on Monday.

The broker trimmed its 12-month price target from $46.50 to $44.50.

This implies a potential 14% upside ahead.

Cleanaway Waste Management Ltd (ASX: CWY)

Cleanaway Waste Management shares are steady at $3 on Friday.

Morgans downgraded Cleanaway Waste Management shares from buy to hold.

The broker has a share price target of $3.10, suggesting 3% upside ahead.

Cleanaway has agreed to a takeover by EQT Infrastructure for $3.095 per share.

Regis Resources Ltd (ASX: RRL)

The Regis Resources Ltd share price is $6.07, down 4.9% today.

Over the past month, this ASX 200 gold mining stock has fallen 24%.

Morgans downgraded Regis Resources shares to a hold rating on Wednesday.

The broker has a 12-month price target of $6.46.

This implies a potential 4% upside ahead.

FleetPartners Group Ltd (ASX: FPR)

The FleetPartners share price is $5.12, down 0.4% today.

Over the past month, this ASX 200 financial stock has risen 10%.

Ord Minnett downgraded FleetPartners shares to a hold rating on Tuesday.

The broker has a target price of $5.30, which implies 3% upside ahead.

Clinuvel Pharmaceuticals Ltd (ASX: CUV)

Clinuvel Pharmaceuticals shares are $7.02, down 0.7% on Friday.

Over the past month, this ASX healthcare stock has fallen 15%.

Morgans downgraded Clinuvel shares to a hold call this week.

The broker slashed its 12-month price target from $10 to $7.

This implies a potential 1% downside ahead.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man sitting in a plane seat works on his laptop.
Broker Notes

Qantas shares were just downgraded but I still rate them as a buy

I think the downgrade was wrong and see value in the airline's shares.

Read more »

Smiling miner.
Broker Notes

4 ASX mining shares with 90% to 155% upside ahead: experts

These ASX mining shares have outstanding price growth potential.

Read more »

A woman smiles at the outlook she sees through binoculars.
Broker Notes

3 ASX shares tipped by brokers to return 48% to 109% over the next 12 months

Find out which ASX share is forecast to climb the highest by this time next year.

Read more »

a water tap is turned on and showering out banknotes into the open hand of a woman below it.
Broker Notes

This ASX small cap could jump 262% over the next year, one analyst says

This water technology company is having a strong year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Broker Notes

Woolworths, NextDC, Telstra shares: Buy, sell, or hold?

Here’s what the experts tip for these three major ASX shares.

Read more »

Man and woman sitting at table with the man looking a bit puzzled at his laptop.
Broker Notes

Buy, hold, sell: Wisetech Global, Wesfarmers, CSL shares

Christopher Watt from Bell Potter explains his ratings on 3 ASX 200 sector heavyweights.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

3 buy-rated biotechnology companies, including one which could jump 400%

If you're looking for exposure to healthcare, these companies could be worth a look.

Read more »

a young boy dressed in a business suit and wearing thick black glasses peers straight ahead while sitting at a heavy wooden desk with an old-fashioned calculator and adding machine while holding a pen over a large ledger book.
Broker Notes

Is the Xero share price too cheap to ignore?

If the company's growth plans stack up, this share could be one to watch.

Read more »